Concepts (210)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Behavior, Addictive | 8 | 2022 | 137 | 3.590 |
Why?
|
| Reversal Learning | 11 | 2022 | 18 | 2.870 |
Why?
|
| Decision Making | 12 | 2022 | 694 | 2.810 |
Why?
|
| Cocaine | 4 | 2022 | 81 | 2.480 |
Why?
|
| Reward | 12 | 2024 | 209 | 2.090 |
Why?
|
| Receptors, Dopamine D2 | 7 | 2014 | 57 | 1.660 |
Why?
|
| Methamphetamine | 6 | 2020 | 104 | 1.420 |
Why?
|
| Conditioning, Operant | 9 | 2022 | 68 | 1.380 |
Why?
|
| Dopamine | 9 | 2025 | 283 | 1.310 |
Why?
|
| Prefrontal Cortex | 8 | 2024 | 150 | 1.310 |
Why?
|
| Substance-Related Disorders | 5 | 2025 | 451 | 1.260 |
Why?
|
| Cocaine-Related Disorders | 2 | 2020 | 41 | 1.230 |
Why?
|
| Goals | 2 | 2020 | 68 | 1.140 |
Why?
|
| Rats | 13 | 2022 | 4155 | 1.060 |
Why?
|
| Corpus Striatum | 4 | 2020 | 92 | 1.030 |
Why?
|
| Discrimination Learning | 5 | 2014 | 65 | 1.020 |
Why?
|
| Models, Psychological | 4 | 2020 | 166 | 0.950 |
Why?
|
| Brain | 9 | 2022 | 2482 | 0.950 |
Why?
|
| Neurosciences | 3 | 2021 | 53 | 0.930 |
Why?
|
| Central Nervous System Stimulants | 3 | 2025 | 235 | 0.920 |
Why?
|
| Animals | 43 | 2025 | 28891 | 0.910 |
Why?
|
| Rats, Long-Evans | 7 | 2022 | 49 | 0.810 |
Why?
|
| Putamen | 2 | 2013 | 14 | 0.790 |
Why?
|
| Habits | 4 | 2021 | 17 | 0.760 |
Why?
|
| Impulsive Behavior | 5 | 2020 | 290 | 0.750 |
Why?
|
| Behavior, Animal | 7 | 2018 | 394 | 0.740 |
Why?
|
| Receptors, Dopamine D3 | 3 | 2020 | 18 | 0.720 |
Why?
|
| Mental Disorders | 2 | 2017 | 463 | 0.640 |
Why?
|
| Astrocytes | 1 | 2020 | 151 | 0.630 |
Why?
|
| Feedback, Physiological | 2 | 2019 | 69 | 0.570 |
Why?
|
| Brain Chemistry | 1 | 2018 | 120 | 0.570 |
Why?
|
| Periodicals as Topic | 1 | 2020 | 171 | 0.570 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2013 | 29 | 0.490 |
Why?
|
| Self Administration | 3 | 2020 | 76 | 0.470 |
Why?
|
| Positron-Emission Tomography | 7 | 2022 | 353 | 0.460 |
Why?
|
| Endocannabinoids | 3 | 2021 | 27 | 0.460 |
Why?
|
| Blinking | 1 | 2014 | 17 | 0.440 |
Why?
|
| Frontal Lobe | 2 | 2013 | 131 | 0.440 |
Why?
|
| Male | 28 | 2024 | 45863 | 0.440 |
Why?
|
| Paranoid Disorders | 3 | 2024 | 6 | 0.400 |
Why?
|
| Synaptic Transmission | 3 | 2017 | 233 | 0.380 |
Why?
|
| Choice Behavior | 3 | 2020 | 165 | 0.360 |
Why?
|
| Neuroimaging | 1 | 2013 | 135 | 0.360 |
Why?
|
| Serotonin | 1 | 2013 | 219 | 0.350 |
Why?
|
| Neurobiology | 2 | 2020 | 10 | 0.330 |
Why?
|
| Mesencephalon | 2 | 2020 | 69 | 0.320 |
Why?
|
| Nucleus Accumbens | 2 | 2020 | 113 | 0.290 |
Why?
|
| Motivation | 2 | 2022 | 310 | 0.280 |
Why?
|
| Cognition Disorders | 3 | 2015 | 244 | 0.260 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 188 | 0.250 |
Why?
|
| Time Factors | 5 | 2016 | 5580 | 0.240 |
Why?
|
| Limbic System | 1 | 2025 | 25 | 0.230 |
Why?
|
| Culture | 2 | 2024 | 54 | 0.220 |
Why?
|
| Analysis of Variance | 4 | 2016 | 908 | 0.220 |
Why?
|
| Glutamic Acid | 2 | 2025 | 159 | 0.210 |
Why?
|
| Monoacylglycerol Lipases | 2 | 2021 | 3 | 0.210 |
Why?
|
| Phencyclidine | 2 | 2014 | 7 | 0.200 |
Why?
|
| Sex Characteristics | 2 | 2017 | 339 | 0.200 |
Why?
|
| Cognition | 3 | 2014 | 635 | 0.200 |
Why?
|
| Receptor, Metabotropic Glutamate 5 | 1 | 2022 | 5 | 0.190 |
Why?
|
| Synapses | 2 | 2015 | 291 | 0.180 |
Why?
|
| Receptors, GABA | 1 | 2022 | 11 | 0.180 |
Why?
|
| Humans | 17 | 2025 | 96105 | 0.180 |
Why?
|
| Photic Stimulation | 3 | 2014 | 514 | 0.180 |
Why?
|
| Schizophrenia | 2 | 2016 | 532 | 0.180 |
Why?
|
| Models, Neurological | 2 | 2019 | 434 | 0.180 |
Why?
|
| Algorithms | 2 | 2021 | 2015 | 0.170 |
Why?
|
| Nerve Tissue Proteins | 2 | 2022 | 515 | 0.170 |
Why?
|
| Cues | 1 | 2022 | 189 | 0.170 |
Why?
|
| Neostriatum | 1 | 2020 | 25 | 0.170 |
Why?
|
| Consummatory Behavior | 1 | 2020 | 1 | 0.160 |
Why?
|
| Uncertainty | 2 | 2020 | 82 | 0.160 |
Why?
|
| Extinction, Psychological | 1 | 2020 | 21 | 0.160 |
Why?
|
| Ventral Tegmental Area | 1 | 2020 | 46 | 0.160 |
Why?
|
| Attitude to Health | 1 | 2021 | 226 | 0.160 |
Why?
|
| Membrane Glycoproteins | 1 | 2022 | 453 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2013 | 1973 | 0.160 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2020 | 44 | 0.160 |
Why?
|
| Diphtheria Toxin | 1 | 2019 | 22 | 0.150 |
Why?
|
| Learning | 1 | 2022 | 305 | 0.150 |
Why?
|
| Glycerides | 1 | 2019 | 13 | 0.150 |
Why?
|
| Arachidonic Acids | 1 | 2019 | 38 | 0.150 |
Why?
|
| Eating | 1 | 2020 | 165 | 0.150 |
Why?
|
| Age Factors | 3 | 2020 | 1963 | 0.150 |
Why?
|
| Ventral Striatum | 1 | 2018 | 6 | 0.150 |
Why?
|
| Amygdala | 1 | 2019 | 87 | 0.140 |
Why?
|
| Benzazepines | 2 | 2017 | 65 | 0.140 |
Why?
|
| Neurons | 2 | 2019 | 1653 | 0.140 |
Why?
|
| Schizophrenic Psychology | 2 | 2016 | 141 | 0.130 |
Why?
|
| Delusions | 1 | 2017 | 12 | 0.130 |
Why?
|
| Association Learning | 1 | 2017 | 38 | 0.130 |
Why?
|
| Oxazines | 1 | 2016 | 15 | 0.120 |
Why?
|
| Food Deprivation | 1 | 2016 | 23 | 0.120 |
Why?
|
| Female | 11 | 2024 | 50028 | 0.120 |
Why?
|
| Disease Susceptibility | 2 | 2014 | 220 | 0.120 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 287 | 0.120 |
Why?
|
| Dopamine Agents | 1 | 2016 | 32 | 0.120 |
Why?
|
| Feeding Behavior | 1 | 2019 | 338 | 0.120 |
Why?
|
| Interneurons | 1 | 2017 | 106 | 0.120 |
Why?
|
| Autistic Disorder | 1 | 2017 | 150 | 0.120 |
Why?
|
| Receptor, Cannabinoid, CB1 | 3 | 2021 | 13 | 0.120 |
Why?
|
| Air Pollutants, Occupational | 1 | 2015 | 6 | 0.110 |
Why?
|
| Models, Statistical | 1 | 2018 | 594 | 0.110 |
Why?
|
| Phenols | 1 | 2015 | 42 | 0.110 |
Why?
|
| Benzhydryl Compounds | 1 | 2015 | 45 | 0.110 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2015 | 23 | 0.110 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 31 | 0.110 |
Why?
|
| Food Preferences | 1 | 2014 | 27 | 0.110 |
Why?
|
| Biogenic Monoamines | 2 | 2011 | 9 | 0.110 |
Why?
|
| Sex Chromosomes | 1 | 2014 | 60 | 0.100 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2013 | 15 | 0.100 |
Why?
|
| Computational Biology | 1 | 2017 | 586 | 0.100 |
Why?
|
| Spinal Cord | 1 | 2014 | 252 | 0.100 |
Why?
|
| Visceral Pain | 1 | 2013 | 6 | 0.100 |
Why?
|
| Caudate Nucleus | 1 | 2013 | 16 | 0.100 |
Why?
|
| Brain Mapping | 1 | 2016 | 594 | 0.100 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 2534 | 0.100 |
Why?
|
| Memory, Short-Term | 3 | 2015 | 244 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2016 | 3639 | 0.100 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2013 | 46 | 0.090 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2012 | 12 | 0.090 |
Why?
|
| HIV Infections | 1 | 2022 | 974 | 0.090 |
Why?
|
| Protein Binding | 1 | 2016 | 1560 | 0.090 |
Why?
|
| Homovanillic Acid | 1 | 2012 | 35 | 0.090 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2012 | 37 | 0.090 |
Why?
|
| Feedback, Sensory | 1 | 2012 | 31 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2016 | 1158 | 0.090 |
Why?
|
| Heterocyclic Compounds, 4 or More Rings | 1 | 2011 | 12 | 0.090 |
Why?
|
| Cebus | 1 | 2011 | 19 | 0.090 |
Why?
|
| Macaca mulatta | 2 | 2024 | 485 | 0.080 |
Why?
|
| Drug Administration Schedule | 1 | 2012 | 873 | 0.080 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 151 | 0.080 |
Why?
|
| Models, Biological | 1 | 2016 | 1809 | 0.070 |
Why?
|
| Biomarkers | 2 | 2016 | 1930 | 0.070 |
Why?
|
| Risk-Taking | 1 | 2010 | 163 | 0.070 |
Why?
|
| Mice | 5 | 2022 | 12537 | 0.070 |
Why?
|
| Basal Ganglia | 1 | 2008 | 47 | 0.070 |
Why?
|
| Memory Disorders | 1 | 2007 | 72 | 0.070 |
Why?
|
| Motor Activity | 2 | 2020 | 332 | 0.060 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2013 | 647 | 0.060 |
Why?
|
| Sex Factors | 2 | 2022 | 1133 | 0.060 |
Why?
|
| Pattern Recognition, Visual | 1 | 2007 | 162 | 0.060 |
Why?
|
| Cerebral Cortex | 1 | 2008 | 615 | 0.050 |
Why?
|
| Neuropsychological Tests | 3 | 2015 | 549 | 0.050 |
Why?
|
| Exploratory Behavior | 2 | 2017 | 49 | 0.050 |
Why?
|
| Thalamus | 1 | 2024 | 135 | 0.050 |
Why?
|
| Down-Regulation | 2 | 2014 | 526 | 0.050 |
Why?
|
| Amidohydrolases | 1 | 2021 | 18 | 0.040 |
Why?
|
| Masks | 1 | 2021 | 31 | 0.040 |
Why?
|
| Infection Control | 1 | 2021 | 132 | 0.040 |
Why?
|
| Optogenetics | 1 | 2020 | 46 | 0.040 |
Why?
|
| Cannabinoid Receptor Antagonists | 1 | 2019 | 2 | 0.040 |
Why?
|
| Lithium Chloride | 1 | 2019 | 3 | 0.040 |
Why?
|
| Lipoprotein Lipase | 1 | 2019 | 14 | 0.040 |
Why?
|
| Health Policy | 1 | 2021 | 208 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 3489 | 0.040 |
Why?
|
| Drug-Seeking Behavior | 1 | 2019 | 12 | 0.040 |
Why?
|
| Benzodioxoles | 1 | 2019 | 15 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2020 | 393 | 0.040 |
Why?
|
| TRPV Cation Channels | 1 | 2019 | 16 | 0.040 |
Why?
|
| Central Nervous System Depressants | 1 | 2019 | 45 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2020 | 333 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2019 | 161 | 0.030 |
Why?
|
| Piperidines | 1 | 2019 | 171 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2021 | 656 | 0.030 |
Why?
|
| Prepulse Inhibition | 1 | 2017 | 4 | 0.030 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2017 | 9 | 0.030 |
Why?
|
| Stereotyped Behavior | 1 | 2017 | 13 | 0.030 |
Why?
|
| Methylazoxymethanol Acetate | 1 | 2016 | 1 | 0.030 |
Why?
|
| Ethanol | 1 | 2019 | 270 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2016 | 76 | 0.030 |
Why?
|
| Inflammation | 1 | 2022 | 1063 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1957 | 0.030 |
Why?
|
| Multimodal Imaging | 1 | 2016 | 115 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 880 | 0.030 |
Why?
|
| Dendritic Spines | 1 | 2015 | 16 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 325 | 0.030 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 2014 | 3 | 0.030 |
Why?
|
| Pyramidal Cells | 1 | 2015 | 89 | 0.030 |
Why?
|
| Anxiety | 1 | 2017 | 339 | 0.030 |
Why?
|
| Serotonergic Neurons | 1 | 2014 | 5 | 0.030 |
Why?
|
| Microscopy, Electron | 1 | 2015 | 510 | 0.030 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2014 | 50 | 0.030 |
Why?
|
| Taste | 1 | 2014 | 29 | 0.030 |
Why?
|
| Social Behavior | 1 | 2017 | 309 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 286 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1267 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2017 | 1645 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2013 | 297 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2017 | 1828 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2015 | 357 | 0.020 |
Why?
|
| Dibenzocycloheptenes | 1 | 2011 | 1 | 0.020 |
Why?
|
| Muscimol | 1 | 2010 | 18 | 0.020 |
Why?
|
| GABA Agonists | 1 | 2010 | 19 | 0.020 |
Why?
|
| Baclofen | 1 | 2010 | 16 | 0.020 |
Why?
|
| Chronic Pain | 1 | 2013 | 186 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 938 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2010 | 214 | 0.020 |
Why?
|
| Genotype | 1 | 2014 | 1881 | 0.020 |
Why?
|
| Probability | 1 | 2010 | 365 | 0.020 |
Why?
|
| Psychomotor Performance | 1 | 2011 | 505 | 0.020 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2007 | 11 | 0.020 |
Why?
|
| Raclopride | 1 | 2007 | 3 | 0.020 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2007 | 7 | 0.020 |
Why?
|
| Adult | 2 | 2020 | 28721 | 0.020 |
Why?
|
| Dopamine Antagonists | 1 | 2007 | 34 | 0.020 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2007 | 34 | 0.020 |
Why?
|
| Reaction Time | 1 | 2007 | 323 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 5961 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2011 | 9175 | 0.010 |
Why?
|